Traditionally, pharmaceutical companies have been slow to adopt these newer technologies, instead relying on well-established and proven - but usually complex - manufacturing processes. However, the time to begin investing in - and exploring - AI, machine learning, and big data is now.
Read More...
No comments:
Post a Comment